Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more
Advanced biologic drugs and COVID-19 vaccines creating opportunities for packaging providers to supply big pharma companies: GlobalData Read more